ES488747A0 - Metodo de analizar fluidos corporales. - Google Patents

Metodo de analizar fluidos corporales.

Info

Publication number
ES488747A0
ES488747A0 ES488747A ES488747A ES488747A0 ES 488747 A0 ES488747 A0 ES 488747A0 ES 488747 A ES488747 A ES 488747A ES 488747 A ES488747 A ES 488747A ES 488747 A0 ES488747 A0 ES 488747A0
Authority
ES
Spain
Prior art keywords
body fluids
analyzing body
analyzing
fluids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES488747A
Other languages
English (en)
Other versions
ES8102679A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP943579A external-priority patent/JPS55101860A/ja
Priority claimed from JP14174179A external-priority patent/JPS5664659A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8102679A1 publication Critical patent/ES8102679A1/es
Publication of ES488747A0 publication Critical patent/ES488747A0/es
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES488747A 1979-01-30 1980-01-29 Metodo de analizar fluidos corporales. Granted ES488747A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP943579A JPS55101860A (en) 1979-01-30 1979-01-30 Method of diagnosing cancer
JP14174179A JPS5664659A (en) 1979-11-01 1979-11-01 Quantitative method of glycoprotein in connection with cancer

Publications (2)

Publication Number Publication Date
ES8102679A1 ES8102679A1 (es) 1981-02-16
ES488747A0 true ES488747A0 (es) 1981-02-16

Family

ID=26344157

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488747A Granted ES488747A0 (es) 1979-01-30 1980-01-29 Metodo de analizar fluidos corporales.

Country Status (10)

Country Link
US (1) US4389392A (es)
CH (1) CH645728A5 (es)
DE (1) DE3003301C2 (es)
DK (1) DK36980A (es)
ES (1) ES488747A0 (es)
FR (1) FR2461256A1 (es)
GB (1) GB2043890B (es)
IT (1) IT1165552B (es)
NL (1) NL8000536A (es)
SE (1) SE451508B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002296A1 (en) * 1979-04-16 1980-10-30 Massachusetts Inst Technology Enzymatic method for detecting cancer in mammalian tissue
DE3003836A1 (de) * 1980-02-02 1981-08-13 Merck Patent Gmbh, 6100 Darmstadt Verfahren und mittel zur bestimmung einer komponente aus einer gruppe bestehend aus spezifisch bindenden rezeptoren und substanzen, die von diesen rezeptoren spezifisch gebunden werden koennen
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
GB2093993A (en) * 1980-07-25 1982-09-08 Otsuka Pharma Co Ltd Method for determining tumor-associated glucose side chain method for diagnosing tumors and kit for diagnosing tumors
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4455380A (en) * 1982-01-29 1984-06-19 Otsuka Pharmaceutical Co., Ltd. Process for determining tumor-associated glycolinkage
FR2520877B1 (fr) * 1982-01-29 1987-07-03 Otsuka Pharma Co Ltd Procede pour la determination des composes a liaisons gluco associes aux tumeurs
US4507391A (en) * 1982-04-02 1985-03-26 Sloan-Kettering Institute For Cancer Research Method for detecting the presence of GD3 ganglioside
EP0155938A1 (en) * 1983-09-28 1985-10-02 Summa Medical Corporation Lectin composition and method for diagnosis of cancer
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
FI852545L (fi) * 1984-06-29 1985-12-30 Ortho Diagnostic Systems Inc Sandwichanalys av antikroppslektin.
JPH06105257B2 (ja) * 1984-08-07 1994-12-21 協和メデックス株式会社 癌の測定用キット
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
AU6126186A (en) * 1985-07-01 1987-01-30 Trustees Of Columbia University In The City Of New York, The Lectin-antibody sandwich assay for desialylated glycoproteins
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
US5403717A (en) * 1987-08-11 1995-04-04 Pacific Northwest Research Diagnosis of premalignant or malignant conditions of human secretory epithelia
IT1230673B (it) * 1987-09-04 1991-10-29 Sclavo Spa Metodo per la immunolocalizzazione di antigeni con l'impiego di anticorpi diretti contro epitopi di natura non glucidica
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US5051354A (en) * 1988-04-15 1991-09-24 Abbott Laboratories Detection of altered IGA1 in fluid samples
TW201305B (es) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
AU657102B2 (en) * 1991-04-12 1995-03-02 Bio-Rad Laboratories, Inc. CA 195-like immunoreactive antigen from human amniotic fluid
WO1994014071A1 (en) * 1992-12-10 1994-06-23 Novik, Anatoly Matveevich Method of diagnosing malignant tumours in humans
DE69422692T2 (de) * 1993-11-16 2000-07-06 Wako Pure Chem Ind Ltd Verfahren zum Trennen und Messen von Glykoprotein
SE9602545L (sv) * 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
EP1380840A4 (en) * 2001-03-27 2005-08-17 Teikoku Hormone Mfg Co Ltd METHOD OF DIAGNOSING BREAST CANCER
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
DE10249608A1 (de) * 2002-10-18 2004-05-06 Gkss-Forschungszentrum Geesthacht Gmbh Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
US7838634B2 (en) * 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196186A (en) * 1975-10-09 1980-04-01 Samuel Bogoch Method for diagnosing malignant gliol brain tumors
US4298590A (en) * 1975-02-25 1981-11-03 Samuel Bogoch Detection of malignant tumor cells
GB1533464A (en) * 1975-02-18 1978-11-22 Bogoch S Cancer diagnostic agents
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4132767A (en) * 1976-04-05 1979-01-02 Eisai Co., Ltd. Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4289747A (en) * 1978-12-26 1981-09-15 E-Y Laboratories, Inc. Immunological determination using lectin
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis

Also Published As

Publication number Publication date
CH645728A5 (fr) 1984-10-15
IT8047743A0 (it) 1980-01-29
GB2043890B (en) 1983-09-07
GB2043890A (en) 1980-10-08
SE8000705L (sv) 1980-07-31
FR2461256A1 (fr) 1981-01-30
DK36980A (da) 1980-07-31
IT1165552B (it) 1987-04-22
FR2461256B1 (es) 1983-11-10
SE451508B (sv) 1987-10-12
ES8102679A1 (es) 1981-02-16
DE3003301A1 (de) 1980-07-31
US4389392A (en) 1983-06-21
DE3003301C2 (de) 1983-12-01
IT8047743A1 (it) 1981-07-29
NL8000536A (nl) 1980-08-01

Similar Documents

Publication Publication Date Title
ES488747A0 (es) Metodo de analizar fluidos corporales.
ES488927A0 (es) Metodo para la recogida de plasma sanguineo.
FI821254A0 (fi) Medicinskt instrument
ES501130A0 (es) Procedimiento de obtencion de mucopolisacaridos
BE884150A (nl) Fluidumfitting
IT7924824A0 (it) Metodo diagnostico.
ES261264Y (es) Endoprotesis de cabeza variable.
ES516555A0 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ES269846Y (es) Disposicion de tratamiento de pestanas.
ES517862A0 (es) Derivados de alcanosulfonanilida.
BR8206791A (pt) Valvula de corredica deslizante
NL187963C (nl) Chirurgische hechtdraad.
IT1109621B (it) Reattivo per la rivelazione e per la determinazione di enzimi
SE8005123L (sv) Enzymimmunologisk bestemningsmetod
BR8000217A (pt) Oxigenador de sangue
BR8200858A (pt) Valvula de corredica
NO156997C (no) Fremgangsmaate for analyse av substanser.
ES494390A0 (es) Metodo de analizar fluidos corporales.
IT8122813A0 (it) Procedimento di preparazione di n-cicloesilbenzotiazol-2-solfenammi de.
ES517942A0 (es) Procedimiento de obtener alcaloides bisindolicos.
IT1209301B (it) Utilizzazione di precursori biochimici dei glucosaminglicani.
ES510963A0 (es) Procedimiento de preparacion de alcoxiaminohidridosilanos.
IT8224763A0 (it) Procedimento per la misurazione quantitativa di fosfatidilglicerina.
ES497763A0 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
ES520026A0 (es) Procedimiento para la obtencion de oximcarbamatos n-sulfenilados.